Evidence map›Paper›PMID 30702780›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2019

Modular Metal-Organic Polyhedra Superassembly: From Molecular-Level Design to Targeted Drug Delivery.

Wei Zhu, Jimin Guo, Yi Ju, Rita E Serda, Jonas G Croissant, Jin Shang, Eric Coker, Jacob Ongudi Agola, Qi-Zhi Zhong, Yuan Ping and 2 more

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Higher-Order CuAccounts of chemical research · 2025
    Article
  5. A CuJournal of the American Chemical Society · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Anion Binding as a Strategy for the Synthesis of Porous Salts.Chemistry of materials : a publication of the American Chemical Society · 2022
    Article
  10. Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  11. Multifunctional NaLnFNanomaterials (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wei ZhuCenter for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA.
Jimin GuoCenter for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA.
Yi JuARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and The Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia.
Rita E SerdaDepartment of Internal Medicine, Molecular Medicine, The University of New Mexico, Albuquerque, NM, 87131, USA.
Jonas G CroissantCenter for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA.
Jin ShangSchool of Energy and Environment, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong SAR, P. R. China.
Eric CokerSandia National Laboratories, Applied Optical/Plasma Sciences, P.O. Box 5800, MS 1411, Albuquerque, NM, 87185-1411, USA.
Jacob Ongudi AgolaCenter for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA.
Qi-Zhi ZhongARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and The Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia.
Yuan PingCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
Frank CarusoARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and The Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia.
C Jeffrey BrinkerCenter for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA.ORCID https://orcid.org/0000-0002-7145-9324

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Australian Research Council CE140100036National Health Medical Research Council Senior Principal Research Fellowship APP1135806NCI NIH HHS P30 CA118100NIH HHS FP0003261UNM Comprehensive Cancer Center NCI 2P30 CA118100-11U.S. Department of Energy's National Nuclear Security Administration DENA-0003525
6 · The paper itself

Abstract

Targeted drug delivery remains at the forefront of biomedical research but remains a challenge to date. Herein, the first superassembly of nanosized metal-organic polyhedra (MOP) and their biomimetic coatings of lipid bilayers are described to synergistically combine the advantages of micelles and supramolecular coordination cages for targeted drug delivery. The superassembly technique affords unique hydrophobic features that endow individual MOP to act as nanobuilding blocks and enable their superassembly into larger and well-defined nanocarriers with homogeneous sizes over a broad range of diameters. Various cargos are controllably loaded into the MOP with high payloads, and the nanocages are then superassembled to form multidrug delivery systems. Additionally, functional nanoparticles are introduced into the superassemblies via a one-pot process for versatile bioapplications. The MOP superassemblies are surface-engineered with epidermal growth factor receptors and can be targeted to cancer cells. In vivo studies indicated the assemblies to have a substantial circulation half-life of 5.6 h and to undergo renal clearance-characteristics needed for nanomedicines.

Indexed as

A549 CellsAnimalsAntineoplastic AgentsCell SurvivalDelayed-Action PreparationsDoxorubicinDrug CarriersDrug LiberationErbB ReceptorsHumansHydrophobic and Hydrophilic InteractionsMacromolecular SubstancesMetalsMiceMicellesModels, AnimalAntineoplastic AgentsDelayed-Action PreparationsDoxorubicinDrug CarriersErbB ReceptorsMacromolecular SubstancesMetalsMicellesOrganometallic Compoundsmetal-organic polyhedramicellesnanoparticlessuperassemblytargeted drug delivery

Identifiers

PMID30702780
PMCPMC7482105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.